1. Home
  2. ATNM vs MAXN Comparison

ATNM vs MAXN Comparison

Compare ATNM & MAXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATNM
  • MAXN
  • Stock Information
  • Founded
  • ATNM 2000
  • MAXN 2019
  • Country
  • ATNM United States
  • MAXN Singapore
  • Employees
  • ATNM N/A
  • MAXN N/A
  • Industry
  • ATNM Biotechnology: Pharmaceutical Preparations
  • MAXN Semiconductors
  • Sector
  • ATNM Health Care
  • MAXN Technology
  • Exchange
  • ATNM Nasdaq
  • MAXN Nasdaq
  • Market Cap
  • ATNM 50.2M
  • MAXN 56.0M
  • IPO Year
  • ATNM N/A
  • MAXN N/A
  • Fundamental
  • Price
  • ATNM $1.61
  • MAXN $3.80
  • Analyst Decision
  • ATNM Strong Buy
  • MAXN Sell
  • Analyst Count
  • ATNM 2
  • MAXN 1
  • Target Price
  • ATNM $4.50
  • MAXN $4.00
  • AVG Volume (30 Days)
  • ATNM 122.2K
  • MAXN 110.8K
  • Earning Date
  • ATNM 11-13-2025
  • MAXN 08-14-2025
  • Dividend Yield
  • ATNM N/A
  • MAXN N/A
  • EPS Growth
  • ATNM N/A
  • MAXN N/A
  • EPS
  • ATNM N/A
  • MAXN N/A
  • Revenue
  • ATNM N/A
  • MAXN $176,414,000.00
  • Revenue This Year
  • ATNM N/A
  • MAXN $100.37
  • Revenue Next Year
  • ATNM N/A
  • MAXN $24.61
  • P/E Ratio
  • ATNM N/A
  • MAXN N/A
  • Revenue Growth
  • ATNM N/A
  • MAXN N/A
  • 52 Week Low
  • ATNM $1.03
  • MAXN $2.49
  • 52 Week High
  • ATNM $2.41
  • MAXN $14.49
  • Technical
  • Relative Strength Index (RSI)
  • ATNM 45.72
  • MAXN 47.42
  • Support Level
  • ATNM $1.60
  • MAXN $3.75
  • Resistance Level
  • ATNM $1.70
  • MAXN $4.18
  • Average True Range (ATR)
  • ATNM 0.07
  • MAXN 0.25
  • MACD
  • ATNM -0.01
  • MAXN 0.01
  • Stochastic Oscillator
  • ATNM 32.14
  • MAXN 43.28

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

About MAXN Maxeon Solar Technologies Ltd.

Maxeon Solar Technologies Ltd is engaged in the manufacturing and marketing of premium solar technology. It owns and operates solar cell and panel manufacturing facilities located in Malaysia, Mexico, and the Philippines. The company's primary products are the Maxeon line of interdigitated back contact (IBC) solar cells and panels, and the Performance line (formerly, P-Series) of shingled solar cells and panels. the Maxeon line of solar panels are the highest-efficiency solar panels on the market with an aesthetically pleasing design, and the Performance line of solar panels offers a high-value and cost-effective solution. It is targeted at residential and small-scale commercial customers across the globe. The company derives its revenue from the United States, France, Italy, and others.

Share on Social Networks: